Pilot trial of ibritumomab tiuxetan (Zevalin) for relapsed lymphoma: efficacy also demonstrated in aggressive lymphoma as a preconditioning regimen before allogeneic non-myeloablative stem cell transplantation
BONE MARROW TRANSPLANTATION（2006）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要